The DOI matches its Crossref record.
Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
Open accessAbstract
We have used in vitro mutagenesis to examine in detail the roles of two modular protein domains, SH2 and SH3, in the regulation of the Abl tyrosine kinase. As previously shown, the SH3 domain suppresses an intrinsic transforming activity of the normally nontransforming c-Abl product in vivo. We show here that this inhibitory activity is extremely position sensitive, because mutants in which the position of the SH3 domain within the protein is subtly altered are fully transforming. In contrast to the case in vivo, the SH3 domain has no effect on the in vitro kinase activity of the purified protein. These results are consistent with a model in which the SH3 domain binds a cellular inhibitory factor, which in turn must physically interact with other parts of the kinase. Unlike the SH3 domain, the SH2 domain is required for transforming activity of activated Abl alleles. We demonstrate that SH2 domains from other proteins (Ras-GTPase-activating protein, Src, p85 phosphatidylinositol 3-kinase subunit, and Crk) can complement the absence of the Abl SH2 domain and that mutants with heterologous SH2 domains induce altered patterns of tyrosine-phosphorylated proteins in vivo. The positive function of the SH2 domain is relatively position independent, and the effect of multiple SH2 domains appears to be additive. These results suggest a novel mechanism for regulation of tyrosine kinases in which the SH2 domain binds to, and thereby enhances the phosphorylation of, a subset of proteins phosphorylated by the catalytic domain. Our data also suggest that the roles of the SH2 and SH3 domains in the regulation of Abl are different in several respects from the roles proposed for these domains in the closely related Src family of tyrosine kinases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Protein Tyrosine Kinase Structure and Function
Hubbard, S. R., & Till, J. H. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.373 · Cited by 1,171
The SCF ubiquitin ligase: insights into a molecular machine
Cardozo, T., & Pagano, M. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1471 · Cited by 1,114
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
Songyang, Z., Carraway, K. L., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., et al. (1995) · Nature · doi:10.1038/373536a0 · Cited by 919
Self-citationMechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL
Azam, M., Latek, R. R., & Daley, G. Q. (2003) · Cell · doi:10.1016/s0092-8674(03)00190-9 · Cited by 613
Li, S., Ilaria, R. L., Million, R. P., Daley, G. Q., & Van Etten, R. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1399 · Cited by 501
Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation
Koleske, A. J., Gifford, A. M., Scott, M. L., Nee, M., Bronson, R. T., Miczek, K. A., & Baltimore, D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80646-7 · Cited by 397
Self-citationSpecific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib
Deininger, M. W. N., & Druker, B. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.4 · Cited by 365
ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
Colicelli, J. (2010) · Science Signaling · doi:10.1126/scisignal.3139re6 · Cited by 347
Jak-STAT Signaling Induced by the v- abl oncogene
Danial, N. N., Pernis, A., & Rothman, P. B. (1995) · Science · doi:10.1126/science.7569929 · Cited by 325
Regulation of Btk Function by a Major Autophosphorylation Site Within the SH3 Domain
Park, H., Wahl, M. I., Afar, D. E. H., Turck, C. W., Rawlings, D. J., Tam, C., Scharenberg, A. M., Kinet, J.-P., & Witte, O. N. (1996) · Immunity · doi:10.1016/s1074-7613(00)80417-3 · Cited by 323
Cycling, stressed-out and nervous: cellular functions of c-Abl
Van Etten, R. A. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01549-4 · Cited by 321
Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
Ren, R., Ye, Z. S., & Baltimore, D. (1994) · Genes & Development · doi:10.1101/gad.8.7.783 · Cited by 311
Self-citationThe Abl family kinases: Mechanisms of regulation and signaling
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)85003-5 · Cited by 296
Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases
Mayer, B. J., Hirai, H., & Sakai, R. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00060-1 · Cited by 284
Self-citationBrasher, B. B., & Van Etten, R. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005401200 · Cited by 278
Dai, Z., & Pendergast, A. M. (1995) · Genes & Development · doi:10.1101/gad.9.21.2569 · Cited by 269
Wen, S.-T., & Van Etten, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.19.2456 · Cited by 265
Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck
Lu, W., Katz, S., Gupta, R., & Mayer, B. J. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00052-2 · Cited by 259
Self-citationAbl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation
Sini, P., Cannas, A., Koleske, A. J., Di Fiore, P. P., & Scita, G. (2004) · Nature Cell Biology · doi:10.1038/ncb1096 · Cited by 130
Kadlec, L., & Pendergast, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12390 · Cited by 58
Metadata
- Authors
- Mayer, B. J., & Baltimore, D.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1994-05
- Volume
- 14
- Issue
- 5
- Pages
- 2883-2894
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W1956850831
- Cited by
- 178
- References
- 0
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.